Form 4 for YARW Yarrow Bioscience, Inc.
Accepted 2025-06-03 00:00:00 ET · period of report 2025-06-02 · accession 0001415889-25-015382 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-03 | 2025-06-02 | YARW | Domzalski David | Pres AND CEO, Dir | A - Grant | $0.81 | +8,681 | 454.2K | +2% | +$7,032 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-06-02 | A | A | 8,681 | $0.81 | 454,244 | D | — | — |